Table 1 General Characteristics of Participants.

From: Hearing impairment and the risk of neurodegenerative dementia: A longitudinal follow-up study using a national sample cohort

Characteristics

Severe hearing impairment

Profound hearing impairment

Hearing impairment

(n, %)

Control group

(n, %)

P-value

Hearing impairment

(n, %)

Control group

(n, %)

P-value

Follow-up (months, mean [standard deviation])

88.61 (±40.85)

88.95 (±41.14)

1.000

124.05 (±31.35)

124.74 (±31.09)

1.000

Age (years old)

  

1.000

  

1.000

   40–44

264 (6.0)

1,056 (6.0)

 

119 (12.4)

467 (12.4)

 

   45–49

327 (7.4)

1,308 (7.4)

 

107 (11.2)

428 (11.2)

 

   50–54

395 (8.9)

1,580 (8.9)

 

105 (11.0)

420 (11.0)

 

   55–59

536 (12.1)

2,144 (12.1)

 

125 (13.0)

500 (13.0)

 

   60–64

701 (15.8)

2,804 (15.8)

 

132 (13.8)

528 (13.8)

 

   65–69

754 (17.0)

3,016 (17.0)

 

126 (13.2)

504 (13.2)

 

   70–74

686 (15.5)

2,744 (15.5)

 

115 (12.0)

460 (12.0)

 

   75–79

487 (11.0)

1,948 (11.0)

 

77 (8.0)

308 (8.0)

 

   80–84

210 (4.7)

842 (4.7)

 

36 (3.8)

144 (3.8)

 

   85+

72 (1.6)

288 (1.6)

 

16 (1.7)

64 (1.7)

 

Sex

  

1.000

  

1.000

   Male

2,432 (54.9)

9,728 (54.9)

 

522 (54.5)

2,088 (54.5)

 

   Female

2,000 (45.1)

8,000 (45.1)

 

436 (45.5)

1,744 (45.5)

 

Income

  

1.000

  

1.000

   health aid (lowest)

357 (8.1)

1,428 (8.1)

 

198 (20.7)

792 (20.7)

 

   health insurance ≤10%

404 (9.1)

1,616 (9.1)

 

83 (8.7)

332 (8.7)

 

   11–20%

271 (6.1)

1,084 (6.1)

 

54 (5.6)

216 (5.6)

 

   21–30%

339 (7.6)

1,356 (7.6)

 

89 (9.3)

356 (9.3)

 

   31–40%

333 (7.5)

1,332 (7.5)

 

69 (7.2)

276 (7.2)

 

   41–50%

355 (8.0)

1,420 (8.0)

 

75 (7.8)

300 (7.8)

 

   51–60%

322 (7.3)

1,288 (7.3)

 

51 (5.3)

204 (5.3)

 

   61–70%

415 (9.4)

1,660 (9.4)

 

83 (8.7)

332 (8.7)

 

   71–80%

420 (9.5)

1,680 (9.5)

 

72 (7.5)

288 (7.5)

 

   81–90%

566 (12.8)

2,264 (12.8)

 

96 (10.0)

384 (10.0)

 

   ≥91% (highest)

650 (14.7)

2,600 (14.7)

 

88 (9.2)

352 (9.2)

 

Region of residence

  

1.000

  

1.000

   Urban

1,778 (40.1)

7,112 (40.1)

 

334 (34.9)

1,336 (34.9)

 

   Rural

2,654 (59.9)

10,616 (59.9)

 

624 (65.1)

2,496 (65.1)

 

Hypertension

  

1.000

  

1.000

   Yes

2,683 (60.5)

10,732 (60.5)

 

462 (51.8)

1,848 (51.8)

 

   No

1,749 (39.5)

6,996 (39.5)

 

496 (48.2)

1,984 (48.2)

 

Diabetes Mellitus

  

1.000

  

1.000

   Yes

1,274 (28.7)

5,096 (28.7)

 

188 (19.6)

752 (19.6)

 

   No

3,158 (71.3)

12,632 (71.3)

 

770 (80.4)

3,080 (80.4)

 

Dyslipidemia

  

1.000

  

1.000

   Yes

1,259 (28.4)

5,063 (28.4)

 

202 (21.1)

808 (21.1)

 

   No

3,173 (71.6)

12,692 (71.6)

 

756 (78.9)

3,024 (78.9)

 

Ischemic heart disease

  

0.060

  

0.562

   Yes

503 (11.3)

1,840 (10.4)

 

83 (8.7)

310 (8.1)

 

   No

3,929 (88.7)

15,888 (89.6)

 

845 (91.3)

3,522 (91.9)

 

Cerebrovascular disease

  

<0.001*

  

0.066

   Yes

999 (22.5)

3,402 (19.2)

 

167 (17.4)

576 (15.0)

 

   No

3,433 (77.5)

14,326 (80.8)

 

791 (8.26)

3,256 (85.0)

 

Depression

  

<0.001*

  

0.291

   Yes

603 (13.6)

1,724 (9.7)

 

66 (6.9)

303 (7.9)

 

   No

3,829 (86.4)

16,004 (90.3)

 

892 (93.1)

3,529 (92.1)

 
  1. *Chi-square test, Significance at P < 0.05.